Association of plasma thrombospondin-1 level with cardiovascular disease and mortality in hemodialysis patients

doi:10.6515/ACS20140630D

淡江大學機構典藏 > 商管學院 > 統計學系暨研究所 > 期刊論文 > Item 987654321/117003

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://tkuir.lib.tku.edu.tw/dspace/handle/987654321/117003

题名:	Association of plasma thrombospondin-1 level with cardiovascular disease and mortality in hemodialysis patients
作者:	Huang, Chi-Lun;Jong, Yuh-Shiun;Wu, Yen-Wen;Wang, Wei-Jie;Hsieh, Ai-Ru;Chao, Chia-Lun;Chen, Wen-Jone;Yang, Wei-Shiung
关键词:	Thrombospondin-1;End-stage renal disease;Cardiovascular disease;Mortality
日期:	2015-05
上传时间:	2019-09-17 12:11:21 (UTC+8)
摘要:	Background Thrombospondin-1 (TSP-1) is known to be involved in the regulation of angiogenesis, inflammation, and vascular function. Clinical studies have demonstrated its correlation with peripheral artery disease, coronary artery disease, and pulmonary hypertension. In this study, we explored its potential roles in the background of end-stage renal disease (ESRD). Methods A total of 140 ESRD outpatients (ages 61.0 ± 12.4 years) were prospectively followed for 34 ± 7 months. Their TSP-1 levels were analyzed from pre-hemodialysis blood sample. Cardiovascular survey included ankle- brachial index (ABI), echocardiography and Tl-201 dipyridamole single-photon emission computed tomography (SPECT). Results Plasma TSP-1 levels were higher in those patients with preexisting clinical evidence of cardiovascular disease (CVD) than those without (p = 0.002). TSP-1 concentrations were also correlated with ABI, left ventricular ejection fraction, and scar burden in SPECT. Stepwise logistic regression analysis revealed that TSP-1 level was independently associated with the presence of CVD, with an odds ratio of 1.38 [95% confidence interval (CI), 1.09-1.75, p = 0.008]. In survival analyses, 31 patients (22%) died during the follow-up, 16 (52%) arising from cardiovascular causes. Cox hazards analysis revealed that the patients with TSP-1 levels in the highest tertile had a 5.32- and 6.75-fold higher risk for all-cause and cardiovascular mortality than those in the lowest tertile. This predictive value for all-cause mortality still persisted after multivariate adjustment (hazard ratio, 8.71; 95% CI, 1.36-55.68; p = 0.02). Conclusions This study hallmarks the association of elevated TSP-1 level with CVD and adverse outcome among hemodialysis patients.
關聯:	Acta Cardiologica Sinica 31(2), p.113-119
DOI:	10.6515/ACS20140630D
显示于类别:	[統計學系暨研究所] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
Association of Plasma Thrombospondin-1 Level with Cardiovascular Disease and Mortality in Hemodialysis Patients.pdf		148Kb	Adobe PDF	0	检视/开启
index.html		0Kb	HTML	56	检视/开启

在機構典藏中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....